Express & Expedited Shipping Service
USD $60.79
AustraliaLa Roche-Posay Anthelios XL Dry Touch SPF50+ is a high-protection sunscreen developed specifically for oily skin. It offers broad-spectrum UVA/UVB protection and is formulated with advanced sun filters to shield your skin from harmful sun exposure.
This sunscreen is ideal for individuals with oily or combination skin types who are looking for a lightweight, non-greasy sun protection solution. It is suitable for daily use and is especially beneficial for those who prefer a matte finish on their skin.
The sunscreen provides extensive sun protection with SPF50+ while maintaining a dry touch, matte finish. It helps to control shine and reduce the appearance of oiliness on the skin. The formula is water-resistant and designed to provide long-lasting protection.
Apply the sunscreen generously to your face and neck as the last step in your skincare routine and before makeup application. Reapply every two hours, especially after swimming, sweating, or towel drying, to maintain optimal sun protection.
Yes, La Roche-Posay Anthelios XL Dry Touch SPF50+ is formulated with gentle ingredients suitable for sensitive skin. It is designed to minimize the risk of allergies, making it a great option for those with sensitive or reactive skin types.
No, the sunscreen is designed to absorb quickly into the skin without leaving a white cast, ensuring a natural look and feel.
Yes, its lightweight and non-greasy formula makes it an excellent base for makeup, providing a smooth and matte surface for foundation and other cosmetics.
This sunscreen stands out due to its advanced sun protection technology, specifically tailored for oily and sensitive skin. It combines high SPF with a non-comedogenic, shine-free formula, making it an ideal choice for daily sun protection.
Health Guides
Oct 21, 2026
Common sun sensitivity medications include doxycycline, hydrochlorothiazide, naproxen and amiodarone. These drugs can cause marked UV-induced skin injury or a delayed, itchy rash after UV light. The safest response combines UV protection with a medication review, rather than changing a dose withou
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
Oct 18, 2026
On a prescription, "take as needed" means taking prescription medication only when the specified symptom or situation occurs. Take it as directed, following the prescribed dose, minimum interval, and maximum daily limit. The abbreviation PRN comes from the Latin pro re nata, meaning "as needed." Und
Oct 17, 2026
Heart failure medications reduce strain on the heart, control fluid buildup, and lower the risk of hospitalization. Several drug classes also improve survival in people with reduced ejection fraction, although medicines don't cure heart failure. Treatment usually combines medicines because each addr
Oct 16, 2026
SGLT2 inhibitors lower blood glucose by helping the kidneys remove glucose through urine. Selected medicines also reduce heart-failure events and slow chronic kidney disease progression, so prescribing decisions extend beyond blood sugar alone. The short answer: SGLT2 inhibitors can benefit people
Oct 15, 2026
Potassium salt substitutes can lower sodium intake and blood pressure, but some hypertension medicines make the extra potassium unsafe. The main concern is hyperkalemia, an elevated blood potassium level that can disturb the heart's rhythm. Safety depends on kidney function, the complete medication
Oct 14, 2026
Rheumatoid arthritis medications control inflammation, relieve symptoms, and help prevent joint damage. Methotrexate is a common first-choice disease-modifying drug for people newly diagnosed with moderate or high disease activity. RA has no cure, so treatment usually continues throughout life, thou
Oct 13, 2026
A COPD diagnosis often leads to several prescriptions, each with a different job. A rescue inhaler eases sudden breathing symptoms. Long-acting bronchodilators are taken daily to control breathlessness and reduce exacerbations. Inhaled corticosteroids may be prescribed for people with recurrent fla
Oct 12, 2026
A gradual reduction can cause withdrawal symptoms, even when the original illness has improved. Plan dose changes with the prescriber, and don't stop abruptly. Before reducing a dose, agree on why treatment is changing, the size and timing of each reduction, expected symptoms, and when to pause. Th
